Page 1, 2, 3,
The metabolic syndrome has no defined etiology that can be targeted by specific
treatment, and its use in predicting risks for cardiovascular disease has
proven disappointing as well (Kohli et al. 2006). Kahn et al. stated that
the new definitions of MSX have major flaws (Kahn R et al. 2005). The definition
of MSX is assumed to predict diabetes and cardiovascular disease (CVD), but
in fact includes diabetes and CVD. The American Heart Association (AHA) and
American Diabetes Association (ADA) have been at odds over the clinical relevance
of the metabolic syndrome. The ADA feels that MSX is poorly defined and misleading,
and there is no consensus of agreement as to the utility of the grouping
of risk factors associated with MSX (Mitka 2006).
It is obvious from the above discussion that the development of MSX is complex
and multi-causal. The condition involves not only genetic, lifestyle, environmental,
and emotional factors; development and progression is greatly influenced by neuroendocrine
and nutritional imbalances.
HTMA may serve as a useful screening tool for assessing individuals with a predisposition
toward MSX. Further research will undoubtedly show that HTMA patterns will provide
not only an indication of MSX but also reveal factors contributing to the underlying
progression of the associated syndromes. HTMA will substantially aid in assessment
of the collective factors, which is necessary for determining a
specific, targeted nutritional approach in treatment and prevention.
In reviewing this paper, one should be cautious about drawing conclusions and
making applications. There are not only biological differences contributing
to diabetes and CVD, but also biological variability among each metabolic type.
One should not assume that there exists a single mineral pattern and, therefore,
a single nutritional approach for all individuals who have MSX. There are several
subtype mineral patterns associated with each metabolic type. Consequently,
person should be assessed and treated as an individual rather than grouped
under a broad category of disease or syndrome. With the recognition of biological
that can be assessed through HTMA and other methods, the concept of one diet
or nutritional approach for diabetes, heart disease, and other health conditions
is obsolete and can no longer be justified. Quoting Ann Coulston, "Changes
in philosophy, scientific recommendations, and terminology shift the nutrition
management of diabetes from a mathematical to a cognitive process…" (Coulston
1994). This statement is true for the treatment of most health conditions and
provides the opportunity for increasing the effectiveness of nutritional therapy.
Dr. David L. Watts, Director of Research
Trace Elements, Incorporated
4501 Sunbelt Drive, Addison, Texas 75001
Fax: (972) 248-4896
Reprinted with permission from Trace Elements,
Inc. Newsletter. January-April
2007; 17 (1,2).
Alrefai H, et al. The endocrine system in diabetes mellitus. Endocrin.
Batzevich, et al. Hair trace element analysis in human ecologicalstudies.
Sci.Total Environ. 1995; 164; 89,98.
Bergman RN, et al. Free fatty acids and pathogenesis of type 2 diabetes
mellitus trends. Endocrinol. Metab. 2000;11,9.
Bjorntorp,P, et al. Hypothalamic origin of the metabolic syndrome x.
Ann.N.Y.Acad.Sci. 18, 1999.
Bogden, JD, et al. Clinical Nutrition of the
Essential Trace Elements and Minerals. New Jersey: Humana Press; 2000.
Bondy PK, et.al. Metabolic Control and Disease. New York: W.B.Saunders;1980.
Bowman B, Russell R., Eds. Present Knowledge
in Nutrition, 8th Ed.
Washington, DC: ILSI Press; 2001.
Bujaiska I, et al. Does Central Obesity Reflect "Cushing's
Disease of the Omentum"? Lancet. 1997;349.
Bureau I, et. al. Effect of hepatic iron on hypercholesterolemia and
hypertryglycerolemia in copper-deficient fructose-fed rats. Nutr. 1998;14.
Cebrian A, et.al. Overexpression of parathyroid hormone-related protein
inhibits pancreatic beta-cell death in vivo and in vitro. Diabetes. 2002; 51,10.
Chandra RK. Influences of nutritional status and susceptibility to
infection. Advances In Nutritional Research.Vol. 2. Draper, HH. Ed.
New York: Plenum Pub: 1979.
Coulston A. Nutrition recommendations for people with diabetes mellitus:
A break with tradition. Nutr.Today. 1994; 29,3.
Executive Summary. Conference Highlights. Am.J.Clin.Nutr. 1987.
Feldstein, AE, et al. Free fatty acids promote hepatic lipotoxicity
by stimulating TNF-alpha expression via a lysosomal pathway. Hepatol. 2004; 40,1.
Fields, M, et al. The interaction of type of dietary carbohydrates
with copper deficiency. Am.J.Clin.Nutr. 39,1984.
George K, et al. The metabolic syndrome-a new worldwide definition.
Heaney RP. Long-latency deficiency disease: Insights from calcium and
vitamin D. Am.J.Clin.Nutr. 2003;78.
Gerl H, et.al. Improvement of diabetes mellitus after excision of a
parathyroid adenoma. Wien. Klin. Woch. 1998;110,23.
Graham TE, et al. Retinol-binding protein 4 and insulin resistance
in lean, obese, and diabetic subjects. NEJM. 2006; 354,24.
Guyton A, Hall J. Textbook of Medical Physiology. Saunders Co. 1996.
Harris NS, et al. The chemical pathology of insulin resistance and
the metabolic syndrome. Med.Lab.Observ. 2004; 36,10.
Hasebe N. Oxidative stress and magnesium. Clin.Calcium. 2005;15,2.
Hjemdahl P. Stress and the metabolic syndrome. Circul. 2002;106.
Huerta MG, et al. Magnesium deficiency is associated with insulin resistance
in obese children. Diab. Care. 2005; 28,5.
Iitaki M, et al. Insulin resistance in pituitary, thyroid, and adrenal
disease. Nippom, Rinscho. 2000;58.
Iitaka M, et al. Insulin resistance in pituitary, thyroid and adrenal
disease. Nippon Rinsho. 2000;58,2.
Kahn R, et al. The metabolic syndrome. Lancet, 366,9501, 2005.
Kikkoris P, et al. Obesity and endocrine disease. Endocrinol.
Metabol. Clin. N. Amer. 2003; 32, 4.
Klevay LM. Coronary heart disease: The zinc/copper hypothesis. Am.J.Clin.Nutr. 1975; 28.
Klevay LM. The role of copper and zinc in cholesterol metabolism. In
Advances In Nutritional Research. Drapper, HH, Ed. Plen.Pub; 1975.
Koutsari J. Free fatty acid metabolism in human obesity. J.Lipid
Res. May 2006;
Kohli P, Greenland P. Role of the metabolic syndrome in risk assessment
for coronary heart disease. JAMA. 2006; 295: 6,7.
Kurup RK, et al. Hypothalamic digoxin, hemispheric chemical dominance
and syndrome x with multiple lacunar state. A hypothesis. Neurol.
Lal J, et al. Effect of oral magnesium supplementation on the lipid
profile and blood glucose of patients with type 2 diabetes mellitus.
J.Assoc. Phys. India. 2003;51.
Lal, et al. Neutron activation of trace elements in human hair: Effect
of dietary and environmental factors. Int.J.Rad. Appl. Instrum. 1987;
Marx, J. Metabolic defects tied to mitochondrial gene. Science. 2004;306.
Mazur A, et al. Magnesium and the inflammatory response: Potential
physiopathological implications. Arch.Biochem.Biophys. 2006.
McCarty MF, et al. PTH excess may promote weight gain by impeding catecholamine-induced
lipolysis-implications for theimpact of calcium, vitamin D and alcohol
on body weight. Med.Hypoth. 2003;61,5-6.
Medeiros DM, et al. A unified perspective on copper deficiency and
cardiomyopathy. Proc. Soc. For Exp. Biol.
and Med. 1993; 203.
Mitka M. Researchers examine effects of dietary magnesium on type 2
diabetes risk. JAMA. 2004; 291,9.
Mitka M. Groups call truce over metabolic syndrome. JAMA. 2006; 6:
Mooradian, Morley. Am.J.Clin.Nutr. 1987; 45.
Moshen M. A mediterranean-style diet and metabolic syndrome. Nutr.Rev. 2005; 63,9.
Mozaffarian, D, et al. Dietary fats, carbohydrate and progression of
coronary atherosclerosis in postmenopausal women. Am.J.Clin.Nutr. 80,5,
Nordin BEC, ed.
Calcium in Human Biology. New York:
Norman W, et al. Hormones. 2nd Ed. New York: Academic Press; 1997.
Nowak B, et al. Heavy metals in human hair and teeth. The correlation
with metal concentration in the environment. Biol.Trace
Odegaard AO, et al. Trans fatty acids, insulin resistance, and type
2 diabetes. Nutr. Rev. 2006; 64,8.
O'Dell, BL. Dietary carbohydrate source and copper bioavailability.
Ogura M, et al. Unilateral adrenalectomy improves insulin resistance
and diabetes mellitus in a patient with ACTH independent macronodular
adrenal hyperplasia. Endocrin.J. 2003; 50,6.
Oron-Herman, M, et al. Hyperhomocysteinemia as a component of syndrome
x. Metabol. 2003; 52, 11.
Page ME. Degeneration Regeneration. Florida: Nutritional Development
1949. Reprinted 1977.
Page, ME. Body Chemistry in Health and Disease. Florida: Nutritional
Pallholz JE, et al. Arsenic and selenium in human hair: A comparison
of five countries with and without aresnicosis. Biol.Trace
Elem.Res. 2005; 2:106.
Piolino V, et.al. Thermogenic effect of thyroid hormones: Interactions
with epinephrine and insulin. Am.J.Physiol. 1990; 259.
Prohaska JR. Biochemical changes in copper deficiency. J.Nutr.Biochem. 1990;1.
Reaven GM. Banting Lecture. Role of insulin resistance in human disease.
Diabetes. 1988; 37:12.
Reaven GM. The insulin resistance syndrome: Definition and dietary
approaches to treatment. Ann. Rev. Nutr. 2005; 35.
Reaven GM. Banting Lecture 1988. Role of insulin resistance in human
disease. Diabetes. 1988; 37.
Reaven GM. Do high carbohydrate diets prevent the development or attenuate
the manifestations (or both) of syndrome x. A viewpoint strongly against.
Curr. Opin. Lipidol. 1997; 1.
Richards ML, et.al. Diabetes mellitus with hyperparathyroidism: Another
indication for parathyroidectomy. Surg. 1999;126,6.
Rodriguez-Moran M, et al. Oral magnesium supplementation improves insulin
sensitivity and metabolic control in type 2 diabetic subjects: A randomized
double-blind control trial. Diab.Care. 2003;26,4.
Saari, et al. Early and advanced glycation end-products areincreased
in copper deficiency. J.Nutr.Biochem. 1999;10,4 1999.
Sawada Y, et al. PTHrP increases pancreatic beta-cell-specific functions
in well differentiated cells. Mol. Cell Endocrinol. 2001;182,2.
Schuschke DA. Dietary copper in the physiology of microcirculation.
J. Nutr. 1997; 127.
Seelig MS. Consequences of magnesium deficiency on the enhancement
of stress reactions; preventive and therapeutic implications. J.Am.Col.Nutr. 1994;13,5.
Seelig MS. Metabolic syndrome X. Min. Res.
Shulman AI, Mangelsdorf DJ. Retinoid X receptor heterodimers in the
metabolic syndrome. NEJM. 2005;353 (6).
Simopoulos A. Genetic variation and nutrition: Population differences
due to single gene defects and population differences in multifactorial
disease due to polygenic effects.
Nutr. Today. 1995;30 (4).
Srikumar, et al. Trace elements status in healthy subjects switching
from a mixed to a lactovegetarian diet for 13 months. Am.J.Clin.Nutr. 1992; 55.
Sternberg S. Metabolic syndrome guidelines expand. Available at: www.usatoday.com/news/health
Taneja SK, et al. Detection of potential myocardial infarction susceptible
individuals in Indian population: A mathematical model based on copper
and zinc status. Biol.Trace Elem.Res. 2000;75.
Tataranni P, et al. Body fat distribution and energy metabolism in
obese men and women. J. Am.Col.of Nutr. 1994; 13,6.
Toxic trace elements in mammalian hair and nails. EPA-600
Uno K, et.al. Neuronal pathway from the liver modulates
energy expenditure and systemic insulin sensitivity. Science. 2006;312.
Vague J. The degree of masculine differentiation of obesities: A factor
determining predisposition to diabetes, atherosclerosis, gout, and
uric acid calculus disease. Am.J.Clin.Nutr. 1956; 4.
Watson G. Nutrition
and Your Mind. New York: Harper and Row; 1972.
Watts DL. HTMA – Useful as a metabolic indicator. TEI
Newslet. 2005; 16 (1).
Watts DL. Mineral imbalance, endocrines and hair tissue mineral analysis. TEI
Newslet. 1993; 6 (2).
Watts DL. Indications of parathyroid activity in hair tissue mineral
patterns. TLDP. October 1989.
Watts DL. Metabolic manifestation of disease, sympathetic-parasympathetic.
TEI Newslet. 1989; 3 (3).
Watts DL. The immune system and hair tissue mineral patterns. Nutritonal,
neuro-endocrine immunology. TEI Newslet. 1994; 7 (1).
Watts DL. Questions on hormones, heavy metals and other tests. TEI
Newslet. 1999; 11 (3).
Watts DL. Trace elements and neuropsychological problems as reflected
in tissue mineral analysis patterns. J.
Orthomol. Med. 1990; 5 (3).
Watts DL. Neurological effects upon nutritional status. Digest
of Chiro. Econ. May/Jun 1991.
Watts DL. Trace elements and other essential nutrients. clinical application
of tissue mineral analysis. TEI. 1995.
Watts DL. Disease clusters. Clinical observations. TEI
Newsletter. 1990; 5, 4.
Watts DL. Answers to criticism of hair mineral analysis. TEI
Watts, DL. Hair mercury testing. An accepted and valuable test. TEI
News Let. 2000;12,2.
Watts DL, et al. A response to the article; assessment of commercial
laboratories performing hair mineral analysis. JAMA. 2001; 1: 285,1.
Watts DL. Variations in hair trace element concentrations: Importance
of proper specimen collection. TLDP. November 2000.
Watts DL. Identifying disease clusters. Health
Watts DL. Nutrient interrelationships minerals-vitamins-endocrines.
J Orthomol.Med. 1990;5,1.
Watts DL. HTMA – useful as a metabolic indicator. TEI
1989; 3: 3.
Watts DL. The nutritional relationships of iron. J.Orthomol.Med. 1988;
Watts DL. The nutritional relationships of copper. J.
1989; 4 (2).
Watts DL. The nutritional relationships of vitamin A. J.Orthomol.Med. 1991;6,1.
Watts DL. The nutritional relationships of calcium. J.Orthomol.Med. 1990;5,2.
Williams B. Insulin resistance: The shape of things to come. Lancet. 1994; 344.
Page 1, 2, 3,